Literature DB >> 31388856

Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?

Timna Naftali1,2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31388856     DOI： 10.1007/s10620-019-05763-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  23 in total

Review 1.  Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids.

Authors:  Lumír Ondrej Hanus
Journal:  Med Res Rev       Date:  2009-03       Impact factor: 12.944

Review 2.  International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Authors:  A C Howlett; F Barth; T I Bonner; G Cabral; P Casellas; W A Devane; C C Felder; M Herkenham; K Mackie; B R Martin; R Mechoulam; R G Pertwee
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

Review 3.  Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.

Authors:  Ethan B Russo
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

4.  Cannabis use amongst patients with inflammatory bowel disease.

Authors:  Simon Lal; Neeraj Prasad; Manijeh Ryan; Sabrena Tangri; Mark S Silverberg; Allan Gordon; Hillary Steinhart
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-10       Impact factor: 2.566

5.  Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].

Authors:  Celia J A Morgan; Gráinne Schafer; Tom P Freeman; H Valerie Curran
Journal:  Br J Psychiatry       Date:  2010-10       Impact factor: 9.319

6.  [Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease].

Authors:  Esther García-Planella; Laura Marín; Eugeni Domènech; Isabel Bernal; Míriam Mañosa; Yamile Zabana; Miquel A Gassull
Journal:  Med Clin (Barc)       Date:  2007-01-20       Impact factor: 1.725

7.  Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.

Authors:  Timna Naftali; Lihi Bar-Lev Schleider; Iris Dotan; Ephraim Philip Lansky; Fabiana Sklerovsky Benjaminov; Fred Meir Konikoff
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-04       Impact factor: 11.382

8.  The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning.

Authors:  P D Morrison; V Zois; D A McKeown; T D Lee; D W Holt; J F Powell; S Kapur; R M Murray
Journal:  Psychol Med       Date:  2009-04-01       Impact factor: 7.723

9.  Marijuana use patterns among patients with inflammatory bowel disease.

Authors:  Jessica Ravikoff Allegretti; Andrew Courtwright; Matthew Lucci; Joshua R Korzenik; Jonathan Levine
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

10.  Phytochemical and genetic analyses of ancient cannabis from Central Asia.

Authors:  Ethan B Russo; Hong-En Jiang; Xiao Li; Alan Sutton; Andrea Carboni; Francesca del Bianco; Giuseppe Mandolino; David J Potter; You-Xing Zhao; Subir Bera; Yong-Bing Zhang; En-Guo Lü; David K Ferguson; Francis Hueber; Liang-Cheng Zhao; Chang-Jiang Liu; Yu-Fei Wang; Cheng-Sen Li
Journal:  J Exp Bot       Date:  2008       Impact factor: 6.992
View more
  2 in total

1.  Evidence supporting the benefits of marijuana for Crohn's disease and ulcerative colitis is extremely limited: a meta-analysis of the literature.

Authors:  Anna Desmarais; Stephen Smiddy; Sneha Reddy; Mohammed El-Dallal; Jonathan Erlich; Joseph D Feuerstein
Journal:  Ann Gastroenterol       Date:  2020-06-22

Review 2.  The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Joseph Bryant; Wilfred Ngwa
Journal:  Int J Mol Sci       Date:  2021-08-31       Impact factor: 6.208
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.